Matches in Wikidata for { <http://www.wikidata.org/entity/Q66027749> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q66027749 description "clinical trial" @default.
- Q66027749 description "ensayu clínicu" @default.
- Q66027749 description "klinisch onderzoek" @default.
- Q66027749 description "клінічне випробування" @default.
- Q66027749 name "Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C" @default.
- Q66027749 name "Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C" @default.
- Q66027749 type Item @default.
- Q66027749 label "Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C" @default.
- Q66027749 label "Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C" @default.
- Q66027749 prefLabel "Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C" @default.
- Q66027749 prefLabel "Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C" @default.
- Q66027749 P1050 Q66027749-7CCC165F-2252-4CD9-9293-366EFEDA308D @default.
- Q66027749 P1050 Q66027749-879F7404-2381-4896-8330-081F7641FB9E @default.
- Q66027749 P1050 Q66027749-A9232322-FCA7-4FA9-BEE4-13C6D2A91DE5 @default.
- Q66027749 P1050 Q66027749-AAEBD9F2-D5BF-4D83-A25F-A0DE696E5C88 @default.
- Q66027749 P1132 Q66027749-A04DE695-4450-4B4D-B340-69D67B7FF2B5 @default.
- Q66027749 P1476 Q66027749-383680F1-CC29-4DAB-87AB-4512B18F86EC @default.
- Q66027749 P17 Q66027749-3785D79C-74AF-4E92-A826-28CABEA686C3 @default.
- Q66027749 P2899 Q66027749-5C750274-A60A-432D-BA22-6941457BBE22 @default.
- Q66027749 P3098 Q66027749-02769D27-7A45-4175-82FF-CA112D22BDB3 @default.
- Q66027749 P31 Q66027749-F02E2D36-6F89-4533-A204-91863714B4E7 @default.
- Q66027749 P4844 Q66027749-47A14C85-E560-4428-B141-8BC4408BA85B @default.
- Q66027749 P580 Q66027749-B0E745E2-A193-485D-A82D-1E57D3B43D40 @default.
- Q66027749 P6099 Q66027749-44AD5F17-886D-4FB9-86D2-C0BC5596B8B8 @default.
- Q66027749 P767 Q66027749-24B53899-B3F0-423D-8C8F-EEB77C9F0F8C @default.
- Q66027749 P8363 Q66027749-D7321377-CA9A-48B9-9DA2-68D4DAE26004 @default.
- Q66027749 P859 Q66027749-770847E0-EC1A-4010-83C5-A4F08B4BBF8D @default.
- Q66027749 P1050 Q131742 @default.
- Q66027749 P1050 Q154869 @default.
- Q66027749 P1050 Q157661 @default.
- Q66027749 P1050 Q6853 @default.
- Q66027749 P1132 "+320" @default.
- Q66027749 P1476 "An Open Label, Comparative, Multi-Center Study, to Evaluate the Efficacy and Safety of Peginterferon Alfa-2a Plus Ribavirin in the Treatment of Patients With Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C" @default.
- Q66027749 P17 Q865 @default.
- Q66027749 P2899 "+18" @default.
- Q66027749 P3098 "NCT00154869" @default.
- Q66027749 P31 Q30612 @default.
- Q66027749 P4844 Q20817235 @default.
- Q66027749 P580 "2004-06-01T00:00:00Z" @default.
- Q66027749 P6099 Q42824827 @default.
- Q66027749 P767 Q212646 @default.
- Q66027749 P8363 Q78089383 @default.
- Q66027749 P859 Q1418766 @default.